Chubby (@kimmonismus)
Revolution Medicines의 실험적 췌장암 치료제 daraxonrasib이 후기 임상 3상에서 큰 성과를 냈다는 소식입니다. 생존 기간을 크게 늘리고 사망 위험을 낮춘 결과로, AI와 직접 관련은 없지만 바이오 분야의 중요한 혁신 소식입니다.
https://x.com/kimmonismus/status/2043799856037204372
#clinicaltrial #biotech #cancer #drug

Chubby♨️ (@kimmonismus) on X
Your daily dose of good news:
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Experimental drug daraxonrasib delivered stunning Phase 3 results, nearly doubling survival (13.2 vs. 6.7 months) and cutting the risk of death
X (formerly Twitter)Clinical trial shows gene editing works for β-Thalassaemia, too
https://arstechni.ca/Q84k #β-Thalassaemia
#clinicaltrial #geneediting #Science #Health #CRISPR
Clinical trial shows gene editing works for β-Thalassaemia, too
Improved gene editing process reactivates the fetal version of a hemoglobin gene.
Ars TechnicaOral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial
📰 Original title: New pill cuts “bad” cholesterol by 60% in major trial
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️
View full AI summary: https://killbait.com/en/oral-pcsk9-inhibitor-enlicitide-reduces-ldl-cholesterol-by-approximately-60-in-phase-3-trial/?redirpost=cee93522-b80d-43fc-aa95-396287d3e6e5
#health #cholesterol #pcsk9inhibitor #clinicaltrial

Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial
A phase 3 clinical trial published in The New England Journal of Medicine demonstrated that enlicitide, an experimental oral PCSK9 inhibitor developed by Merck, significantly lowered low-density…
KillBait ArchiveEdmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/Here's the third (and last!) entry in a series of blog posts on the #cdisc Dataset-JSON standard. This entry goes over the REST API component and potential issues with it.
Pushing for the future of #clinicaltrial #data (and related to the #pharmaverse and #rstats folks in #biomedicalresearch) and better workflows for running those trials.
https://brianrepko.github.io/blog/posts/2026-03-11-datasetjson-part3/
Dataset-JSON – Learning, Thinking, and Coding
Part 3 - the REST API (and issues)